Loading...

Intellectia LogoIntellectia
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. NCT
NCT logo

NCT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • AI Stock Picker
  • Swing Trading
  • SwingMax Portfolio
  • QuantAI Alpha Pick
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • Financial AI Agent
  • AI Screener
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.174
Open
0.174
VWAP
0.16
Vol
1.82M
Mkt Cap
5.01M
Low
0.140
Amount
290.40K
EV/EBITDA(TTM)
--
Total Shares
30.48M
EV
5.98M
EV/OCF(TTM)
--
P/S(TTM)
--
Intercont (Cayman) Ltd is an investment holding company mainly engaged in the international maritime transportation business. The Company is mainly engaged in the provision of time charter service. In addition, the Company is engaged in the provision of vessel management services. The Company operates its business in domestic and overseas markets.
Show More

Events Timeline

(ET)
2026-02-12
09:10:00
Intercont Releases 2026 Strategic Outlook and Growth Plan
select
2025-12-21 (ET)
2025-12-21
10:50:00
Intercont Receives Nasdaq Non-Compliance Notice, Share Price Below $1
select
2025-12-08 (ET)
2025-12-08
09:30:00
Intercont Signs MOU to Acquire Less Than 50% Stake in Starks Network
select
2025-12-01 (ET)
2025-12-01
09:00:00
Intercont Partners with CINCO to Generate $118.25M in Revenue
select

News

Benzinga
9.5
01-07Benzinga
Tecogen Reports Mixed Quarterly Results, Stock Falls 36%
  • Performance Update: On November 12, Tecogen reported mixed quarterly results, with CEO Abinand Rangesh noting progress with a potential data center customer, yet the stock fell 36% over the past month, indicating market concerns about its performance.
  • Customer Potential: The CEO mentioned that the potential customer is considering Tecogen for three sites, which could lead to significantly more chiller sales than the original letter of intent, although the current stock performance remains weak, suggesting future growth potential.
  • Market Performance: Tecogen's Relative Strength Index (RSI) stands at 26.4, indicating the stock is considered oversold, with a current price of $4.41, reflecting investor caution regarding its future performance.
  • Industry Trends: The significant decline in Tecogen's stock price over the past month highlights challenges faced by the industrial sector, prompting investors to monitor its future market recovery capabilities.
Benzinga
5.0
2025-12-31Benzinga
Vanda Pharmaceuticals' NEREUS Receives FDA Approval, Shares Surge 17.5%
  • FDA Approval: Vanda Pharmaceuticals' NEREUS (tradipitant) has received FDA approval for the prevention of motion-induced vomiting in adults, marking a significant advancement in the company's neuropharmaceutical portfolio and is expected to drive future sales growth.
  • Stock Surge: Following the FDA approval announcement, Vanda's shares jumped 17.5% to $8.26 in pre-market trading, reflecting strong market confidence in the new drug's potential and likely attracting increased investor interest.
  • Market Outlook: The approval of NEREUS not only opens new market opportunities for Vanda Pharmaceuticals but also enhances its market share in the competitive antiemetic drug sector, strengthening the company's long-term profitability prospects.
  • Investor Confidence: This FDA approval boosts investor expectations for Vanda's future performance, potentially prompting more institutional investors to reassess their portfolios, further driving the stock price upward.
SeekingAlpha
7.0
2025-12-22SeekingAlpha
Intercont (Cayman) Gets Nasdaq Notice About Minimum Bid Price Shortfall
  • Compliance Notification: Intercont (Cayman) Limited has received a letter from Nasdaq indicating non-compliance with the minimum bid price requirement.

  • Grace Period: The company may be eligible for an additional grace period if it does not regain compliance by June 15, 2026.

Globenewswire
7.0
2025-12-20Globenewswire
Intercont (NCT) Receives Nasdaq Notification for Non-Compliance with $1 Minimum Bid Price
  • Compliance Notification: On December 15, 2025, Intercont received a notification from Nasdaq due to its ordinary shares closing below $1 for 30 consecutive business days from October 31 to December 12, indicating compliance risk.
  • Compliance Period Established: The company has a compliance period of 180 days, until June 15, 2026, to restore its share price above $1 to avoid further listing risks.
  • Potential Remedial Measures: If compliance is not regained within the period, the company may apply for an additional grace period but must meet other listing standards, potentially including a reverse stock split.
  • Market Impact Assessment: While the notification does not affect the ongoing trading of the stock, it may negatively impact investor confidence, influencing the company's future financing and market performance.
Newsfilter
7.0
2025-12-20Newsfilter
NCT Receives Nasdaq Notification for Non-Compliance with Minimum Bid Price Requirement
  • Stock Price Compliance Issue: On December 15, 2025, NCT received a notification from Nasdaq due to its ordinary shares closing below $1.00 for 30 consecutive business days from October 31 to December 12, indicating compliance risks.
  • Compliance Period Established: Under Nasdaq rules, NCT has a compliance period of 180 days until June 15, 2026, to restore its stock price above $1.00 to avoid delisting.
  • Potential Remedial Measures: If compliance is not achieved within the period, NCT may apply for an additional grace period but must meet other listing standards and may need to consider a reverse stock split.
  • Market Impact Assessment: While this notification does not immediately affect NCT's listing status, it may negatively impact investor confidence, potentially affecting the company's ability to raise funds and its market performance.
Newsfilter
7.5
2025-12-08Newsfilter
NCT Acquires Minority Stake in Starks Network to Advance Blockchain Integration
  • Strategic Partnership: NCT has signed a Memorandum of Understanding to acquire a minority stake in Starks Network, aiming to co-develop the zCloak Network, which signifies a crucial step in NCT's strategic positioning within the digital asset space.
  • Market Potential: The zCloak Network boasts strong competitive advantages in the global Web3 ecosystem, with proprietary frameworks and compliance infrastructure enabling annual revenues of $30-40 million in privacy-preserving identity and compliance verification, indicating significant growth potential.
  • Industry Trends: Global stablecoin transaction volume surpassed that of Visa and Mastercard in 2024, with McKinsey forecasting an accelerating growth rate that could see stablecoin transactions exceed traditional payment volumes within a decade, positioning NCT advantageously in this rapidly evolving market.
  • Technological Innovation: By collaborating with Starks Network, NCT will leverage zCloak's technical infrastructure to explore pathways for tokenizing real-world assets, thereby accelerating enterprise adoption of Web3 technologies and reinforcing its leadership in global shipping services.

Valuation Metrics

The current forward P/E ratio for Intercont (Cayman) Ltd (NCT.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Intercont (Cayman) Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks which can short term gains under 1 $
Intellectia · 29 candidates
Price: $0.10 - $1.00Volume: >= 1,000,000Rsi Category: moderateRelative Vol: >= 1.50Week Price Change Pct: >= $5.00
Ticker
Name
Market Cap$
top bottom
AGL logo
AGL
agilon health inc
244.48M
ENSC logo
ENSC
Ensysce Biosciences Inc
2.26M
AERT logo
AERT
Aeries Technology Inc
21.59M
AIIO logo
AIIO
Robo.ai Inc
62.03M
SKYQ logo
SKYQ
Sky Quarry Inc
12.74M
UPXI logo
UPXI
Upexi Inc
61.39M
stocks under $1 bullish
Intellectia · 185 candidates
Price: <= $1.00Moving Average Relationship: PriceAboveMA20, PriceAboveMA5Macd: bullish
Ticker
Name
Market Cap$
top bottom
ENSC logo
ENSC
Ensysce Biosciences Inc
1.43M
KLTO logo
KLTO
Klotho Neurosciences Inc
35.15M
VEEA logo
VEEA
Veea Inc
21.68M
FMFC logo
FMFC
Kandal M Venture Ltd
7.94M
BYND logo
BYND
Beyond Meat Inc
371.93M
MMA logo
MMA
Mixed Martial Arts Group Ltd
14.62M
stocks under $0.50 with an rsi under 20
Intellectia · 33 candidates
Price: <= $0.50Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
MTEN logo
MTEN
Mingteng International Corp Inc
5.55M
ATPC logo
ATPC
Agape ATP Corp
4.10M
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
CCTG logo
CCTG
CCSC Technology International Holdings Ltd
3.84M
APLT logo
APLT
Applied Therapeutics Inc
14.63M
ZJYL logo
ZJYL
Jin Medical International Ltd
19.82M
stocks under $1 with an rsi under 15
Intellectia · 53 candidates
Price: <= $1.00Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
MTEN logo
MTEN
Mingteng International Corp Inc
5.55M
ATPC logo
ATPC
Agape ATP Corp
4.10M
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
CCTG logo
CCTG
CCSC Technology International Holdings Ltd
3.84M
APLT logo
APLT
Applied Therapeutics Inc
14.63M
ZJYL logo
ZJYL
Jin Medical International Ltd
19.82M

Whales Holding NCT

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Intercont (Cayman) Ltd (NCT) stock price today?

The current price of NCT is 0.1642 USD — it has decreased -11.79

What is Intercont (Cayman) Ltd (NCT)'s business?

Intercont (Cayman) Ltd is an investment holding company mainly engaged in the international maritime transportation business. The Company is mainly engaged in the provision of time charter service. In addition, the Company is engaged in the provision of vessel management services. The Company operates its business in domestic and overseas markets.

What is the price predicton of NCT Stock?

Wall Street analysts forecast NCT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NCT is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Intercont (Cayman) Ltd (NCT)'s revenue for the last quarter?

Intercont (Cayman) Ltd revenue for the last quarter amounts to 31.17 USD, decreased

What is Intercont (Cayman) Ltd (NCT)'s earnings per share (EPS) for the last quarter?

Intercont (Cayman) Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does Intercont (Cayman) Ltd (NCT). have?

Intercont (Cayman) Ltd (NCT) has 24 emplpoyees as of March 05 2026.

What is Intercont (Cayman) Ltd (NCT) market cap?

Today NCT has the market capitalization of 5.01M USD.